Treats venous thrombosis and its extension, pulmonary embolism (PE). ANDA 40301, held by Taro. Warfarin Sodium.
As of Nov 16, 2026, ANDA 40301 (Warfarin Sodium), held by Taro, was first approved by FDA on Jul 15, 1999, with 16 approved supplements and 0 published complete response letters.
Warfarin sodium tablets, USP are indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 15, 1999 | Original application | Approved |
| Warfarin Sodium10MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium1MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium2MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium2.5MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium3MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium4MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium5MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium6MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium7.5MG · tablet;oral | Warfarin Sodium | Rx |
| Sep 27, 2019 | Supplement 34Labeling · Standard review | Approved | None posted |
| Sep 27, 2019 | Supplement 36Labeling · Standard review | Approved | None posted |
| Sep 27, 2019 | Supplement 38Labeling · Standard review | Approved | None posted |
| Nov 14, 2016 | Supplement 33Manufacturing | Approved | None posted |
| Jun 2, 2016 | Supplement 32Labeling · Standard review | Approved | None posted |
| Dec 19, 2012 | Supplement 29Labeling · Standard review | Approved | None posted |
| Mar 27, 2012 | Supplement 26Labeling | Approved | None posted |
| May 20, 2010 | Supplement 24Labeling | Approved | None posted |
| Feb 13, 2004 | Supplement 8Labeling | Approved | None posted |
| Jan 12, 2004 | Supplement 9Labeling | Approved | None posted |
| Dec 23, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Dec 23, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Dec 23, 2002 | Supplement 5Labeling | Approved | None posted |
| Dec 23, 2002 | Supplement 6Manufacturing | Approved | None posted |
| Apr 25, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Feb 1, 2000 | Supplement 2Labeling | Approved | None posted |
| Jul 15, 1999 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters